Incyte Corp
NASDAQ: INCY
$79.37
-$1.12 (-1.4%)
Real Time Data Delayed 15 Min.
INCY Articles
The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility that some of the top names may also become takeover targets this year.
Published:
Biotechnology was an incredible performer in 2013. The analysts at J.P. Morgan think that the huge outperformance may lessen going forward but can stay intact. They think the fundamental backdrop is...
Published:
ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up and coming biotech stocks. After all, sales can grow from close to nothing...
Published:
ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can be treated does....
Published:
Last Updated:
August 21, 2013: Markets opened mixed this morning as traders and investors waited for the afternoon’s release of the July FOMC meeting minutes. Existing home sales rose more than expected in July....
Published:
Last Updated:
ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The company...
Published:
Last Updated:
U.S. equity markets opened higher this morning following an unexpected 0.25% cut in Australia’s key interest rate to a new level of 2.75%. Japan’s Nikkei reopened today after a two-day holiday...
Published:
Last Updated:
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Tuesday, May 7, 2013. They include AIG, Coach, J.C. Penney, T-Mobile US and Tiffany.
Published:
Last Updated:
ThinkstockActive traders and more active investors looking for news lists of stocks to buy or other investing ideas often look at stocks which are very active in trading volume. Some are up big, some...
Published:
Last Updated:
Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector...
Published:
U.S. equity markets opened higher this morning following a string of solid earnings reports yesterday and after markets closed last night. As we note below, earnings results were more mixed today,...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Wednesday. Alcatel-Lucent S.A (NYSE: ALU) raised to Neutral from Sell at...
Published:
ThinkstockThe dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only to heart disease, according to...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far from Wall St. research calls this Thursday: ADTRAN Inc. (NASDAQ: ADTN) cut to Sell at UBS but raised to...
Published:
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you look at the...
Published:
Last Updated: